Literature DB >> 11349710

Apoptosis and chemokine induction after renal ischemia-reperfusion.

M A Daemen1, B de Vries, C van't Veer, T G Wolfs, W A Buurman.   

Abstract

BACKGROUND: One of the earliest prerequisites for the development of inflammation after ischemia-reperfusion (I/R) is local chemokine expression. We recently demonstrated that apoptosis, characterized by intracellular caspase-activation, contributes to the development of inflammation after I/R.
METHODS: The contribution of apoptosis was investigated using the pan-caspase inhibitor Z-Val-Ala-Asp(OMe)-CH2F in a murine model of renal I/R. Renal expression of the chemokines macrophage inflammatory protein-2 (MIP-2) and KC was studied using RT-PCR and immunohistology. Measuring myeloperoxidase activity and serum ureum and creatinine levels assessed neutrophil influx and kidney dysfunction.
RESULTS: We demonstrate renal up-regulation of KC and MIP-2 after 1 to 16 hr of reperfusion. Treatment with the caspase inhibitor Z-Val-Ala-Asp(OMe)-CH2F effectively prevented I/R-induced renal apoptosis, KC, and MIP-2 up-regulation after 2 hr of reperfusion as well as neutrophil influx and functional impairment after 24 hr of reperfusion.
CONCLUSIONS: These data for the first time show that chemokine induction following I/R is dependent on caspase activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11349710     DOI: 10.1097/00007890-200104150-00032

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  15 in total

1.  Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation.

Authors:  Hye J Kim; Jong S Lee; Jung D Kim; Hee J Cha; Ahra Kim; Sun K Lee; Sang C Lee; Byoung S Kwon; Robert S Mittler; Hong R Cho; Byungsuk Kwon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

2.  CXCL1/KC and CXCL2/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation.

Authors:  James K Roche; Tiffany R Keepers; Lisa K Gross; Regina M Seaner; Tom G Obrig
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 3.  The interaction between ischemia-reperfusion and immune responses in the kidney.

Authors:  Hye Ryoun Jang; Gang Jee Ko; Barbara A Wasowska; Hamid Rabb
Journal:  J Mol Med (Berl)       Date:  2009-06-28       Impact factor: 4.599

4.  Protective effect of milk fat globule-epidermal growth factor-factor VIII after renal ischemia-reperfusion injury in mice.

Authors:  Akihisa Matsuda; Rongqian Wu; Asha Jacob; Hidefumi Komura; Mian Zhou; Zhimin Wang; Md Monowar Aziz; Ping Wang
Journal:  Crit Care Med       Date:  2011-09       Impact factor: 7.598

5.  Effect of N-desulfated heparin on hepatic/renal ischemia reperfusion injury in rats.

Authors:  Tong Zhou; Jin-Lian Chen; Wei Song; Feng Wang; Ming-Jun Zhang; Pei-Hua Ni; Jian-Guo Geng
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

6.  Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney.

Authors:  Jaklien C Leemans; Geurt Stokman; Nike Claessen; Kasper M Rouschop; Gwendoline J D Teske; Carsten J Kirschning; Shizuo Akira; Tom van der Poll; Jan J Weening; Sandrine Florquin
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

Review 7.  The innate immune response in ischemic acute kidney injury.

Authors:  Hye Ryoun Jang; Hamid Rabb
Journal:  Clin Immunol       Date:  2008-10-14       Impact factor: 3.969

Review 8.  Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney disease.

Authors:  Kengo Furuichi; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2008-12-16       Impact factor: 2.801

9.  The combination of ischemic preconditioning and liver Bcl-2 overexpression is a suitable strategy to prevent liver and lung damage after hepatic ischemia-reperfusion.

Authors:  Carmen Peralta; José Carlos Perales; Ramón Bartrons; Claudia Mitchell; Hélène Gilgenkrantz; Carme Xaus; Neus Prats; Leticia Fernández; Emilio Gelpí; Julia Panés; Juan Roselló-Catafau
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

10.  Lysophosphatidic acid prevents renal ischemia-reperfusion injury by inhibition of apoptosis and complement activation.

Authors:  Bart de Vries; Robert A Matthijsen; Annemarie A J H M van Bijnen; Tim G A M Wolfs; Wim A Buurman
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.